196 related articles for article (PubMed ID: 32507439)
1. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.
Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
Complement Ther Med; 2020 Jun; 51():102428. PubMed ID: 32507439
[TBL] [Abstract][Full Text] [Related]
2. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
[TBL] [Abstract][Full Text] [Related]
3. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
4. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Kazemi S; Shidfar F; Ehsani S; Adibi P; Janani L; Eslami O
Complement Ther Clin Pract; 2020 Nov; 41():101259. PubMed ID: 33190008
[TBL] [Abstract][Full Text] [Related]
5. Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial.
Sangouni AA; Alizadeh M; Jamalzehi A; Parastouei K
Phytother Res; 2021 Aug; 35(8):4433-4441. PubMed ID: 33974725
[TBL] [Abstract][Full Text] [Related]
6. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
7. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
8. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
[TBL] [Abstract][Full Text] [Related]
10. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
[TBL] [Abstract][Full Text] [Related]
11. The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Fathi M; Alavinejad P; Haidari Z; Amani R
J Trace Elem Med Biol; 2020 Dec; 62():126635. PubMed ID: 32932174
[TBL] [Abstract][Full Text] [Related]
12. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
13. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A
Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673
[TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
[TBL] [Abstract][Full Text] [Related]
15. Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
Rostamizadeh P; Asl SMKH; Far ZG; Ahmadijoo P; Mahmudiono T; Bokov DO; Alsaikhan F; Jannat B; Mazloom Z
Phytother Res; 2022 Oct; 36(10):3949-3956. PubMed ID: 35785498
[TBL] [Abstract][Full Text] [Related]
16. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
[TBL] [Abstract][Full Text] [Related]
17. The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: A double-blind randomized clinical trial.
Pour FK; Aryaeian N; Mokhtare M; Mirnasrollahi Parsa RS; Jannani L; Agah S; Fallah S; Moradi N
Phytother Res; 2020 Dec; 34(12):3367-3378. PubMed ID: 32798261
[TBL] [Abstract][Full Text] [Related]
18. Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Soleimani D; Paknahad Z; Askari G; Iraj B; Feizi A
Adv Biomed Res; 2016; 5():2. PubMed ID: 26955623
[TBL] [Abstract][Full Text] [Related]
19. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
Mahmoudi L; Asadi S; Al-Mousavi Z; Niknam R
Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
